The University of Oxford stated that there was no evidence that the vaccines did not prevent severe omicron variant disease, but that it was prepared to rapidly develop an updated version of its AstraZeneca-developed vaccine if necessary.
Earlier on Tuesday, the director of drug maker Moderna said COVID-19 vaccines were unlikely to be as effective against the new variant, shaking global markets.
The University of Oxford stated that the data on omicron was limited so far and that it would carefully assess the impact of the variant on its vaccine, echoing a statement from AstraZeneca last week.
“Despite the emergence of new variants in the last year, vaccines have continued to provide very high levels of protection against severe disease and there is no evidence so far that omicron is different.”He said in a statement.
“However, we have the necessary tools and processes for the rapid development of an updated vaccine against COVID-19 if necessary ”.
.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
